Dissecting strategies to tune the therapeutic potential of SARS-CoV-2–specific monoclonal antibody CR3022

Caroline Atyeo(Harvard University), Galit Alter(Ragon Institute of MGH, MIT and Harvard)
JCI Insight
January 10, 2021
Cited by 45


Related Papers